CTRI/2026/03/105462尚未招募不适用
To evaluate the in-vivo safety and efficacy of the skin care formulation in terms of reduction in pore appearance on healthy female subjects
Naturis Cosmetics Pvt. Ltd.1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2026年3月16日
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 36
- 试验地点
- 1
研究概览
简要总结
OBJECTIVE :The objective of this study is to evaluate the in-vivo safety and efficacy of the skin care formulation in terms of reduction in pore appearance on healthy female subjects.The evaluation is performed using: Subject Self Evaluation (SSE) , Dermatological Evaluation: Cosmetic Acceptability, Dermatological Evaluation: Efficacy, Chromametry, Digital Photographs
POPULATION : 36 Female subjects are selected for the study.. The subjects selected for this study are healthy females, aged between 18 and 35 years, having pores.STUDY DURATION : 28 days following the first application of the regime.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- Participant and Outcome Assessor Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 35.00 Year(s)（—）
- 性别
- Female
入选标准
- •1.Indian female subjects.
- •2.Healthy subjects 3.Skin is healthy on the studied anatomic unit 4.Having visible pores on skin.
排除标准
- •1 Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2 Having refused to give her assent by not signing the consent form 3 Taking part in another study liable to interfere with this study 4 Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) 5 Having a progressive asthma (either under treatment or last fit in the last 2 years) 6 Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis) 7 Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 8 Being epileptic.
- •9 Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 10 Having cutaneous hypersensitivity.
- •11 Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
- •12 Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
研究者
Dr Niharika Salian
MASCOT-SPINCONTROL India Pvt. Ltd.
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Evaluation of Safety and Hair Removal Effect of a Skin Care ProductCTRI/2026/01/101009RG Biocosmetics33
尚未招募
不适用
Efficacy check of skin care productCTRI/2023/12/060574SATIYA NUTRACEUTICALS PRIVATE LIMITED36
尚未招募
不适用
Safety and Efficacy check of Cosmetic Product on skinCTRI/2024/01/061433KAYA LIMITED36
尚未招募
不适用
Study to Check Safety and Effectiveness of Skin Care ProductsCTRI/2025/09/095327ClayCo. Cosmetics Pvt. Ltd.36
尚未招募
不适用
Study to assess the safety and effectiveness of the product on human volunteersCTRI/2025/08/093104Multani Pharmaceuticals Limited36